You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BCR-ABL Positive (BCR-ABL )

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Chicago, Illinois
  • +5 more
Dec 27, 2021

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +7 more
  • Blinatumomab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Jun 24, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

Active, not recruiting
  • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 2, 2022

Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

Recruiting
  • Myeloproliferative Neoplasm
  • +2 more
  • Online Mindfulness Meditation
  • Internet-Based Webinars
  • San Francisco, California
    University of California San Francisco
Aug 9, 2022

Outcomes in Chronic Myeloid Leukaemia

Completed
  • Chronic Myeloid Leukaemia
    • York, United Kingdom
      Haematological Malignancy Research Network
    Jun 7, 2023

    Asciminib RMP Study

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Asciminib
    • (no location specified)
    Jul 5, 2023

    Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

    Not yet recruiting
    • Chronic Myeloid Leukemia, BCR/ABL-Positive
      • Taipei, Taiwan
        National Taiwan University Hospital
      Jul 24, 2022

      Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 15, 2022

      B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

      Completed
      • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Mar 25, 2022

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical

      Active, not recruiting
      • Acute Lymphoblastic Leukemia
      • +11 more
      • Health Promotion and Education
      • +3 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Jul 24, 2023

      Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

      Recruiting
      • Acute Myeloid Leukemia
      • +4 more
      • Recombinant Interleukin-7
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 26, 2023

      According to Molecular Identification at Diagnosis

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Next Generation Sequencing (DNA and RNA)
      • (no location specified)
      Oct 28, 2022

      Concomitant Medications at CML Diagnosis

      Completed
      • Chronic Myeloid Leukemia
      • the prevalence of comorbid conditions
      • (no location specified)
      Sep 16, 2023

      Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

      Not yet recruiting
      • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
      • (no location specified)
      Jun 7, 2022

      Chronic Myeloid Leukemia Trial in Jena (Venetoclax)

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Jena, Germany
        Universitätsklinikum Jena
      Jan 17, 2023

      Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in France (Nilotinib)

      Completed
      • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
      • Angers, France
      • +9 more
      Aug 17, 2022

      Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Trial in Houston (Asciminib)

      Recruiting
      • Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 1, 2022

      "Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

      Not yet recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
        • Sohag, Egypt
          Sohag University Hospital
        Sep 14, 2022

        Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in

        Active, not recruiting
        • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • +11 more
        • Duarte, California
          City of Hope Medical Center
        Dec 8, 2022

        Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

        Recruiting
        • Acute Biphenotypic Leukemia
        • +13 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 19, 2023

        3rd Line Therapy or More to Treat Adult CML- CP in Real World

        Not yet recruiting
        • Chronic Myeloid Leukemia
        • Asciminib
        • (no location specified)
        Oct 16, 2023

        Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

        Completed
        • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • +4 more
        • Eltrombopag Olamine
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 4, 2022